Platelets serve as the primary peripheral reservoir of amyloid beta (Aβ). However, there is limited research on platelet markers in routine blood examinations, particularly with regard to the large platelet ratio (P-LCR) in Alzheimer’s disease (AD).
This study included 512 AD patients and 205 healthy controls (HCs). Platelet markers and apolipoprotein E (APOE) 4 status were assessed in all participants.
The study revealed that P-LCR was significantly elevated in AD patients compared to HCs. In AD patients carrying APOE4, P-LCR significantly negatively correlated with Montreal Cognitive Assessment scores. There was an observed increasing trend in the rate of change in P-LCR with disease progression. Binary logistic regression analysis indicated that P-LCR may constitute a risk factor for AD, after adjusting for age, sex, APOE4, and body mass index.
P-LCR is associated with disease severity in AD patients carrying APOE4. P-LCR may be a promising marker to reflect platelet activity in AD patients.

P-LCR significantly negatively correlated with MoCA scores in AD patients with APOE4.
The rate of change in P-LCR showed an increasing trend with disease progression.
P-LCR may be a risk factor for AD.

If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.

This post is Copyright: Jiajia Fu,
Xiaohui Lai,
Chongwei Zhang,
Qianqian Wei,
Xueping Chen,
Huifang Shang | May 8, 2024

Wiley: Alzheimer’s & Dementia: Table of Contents